Neurology Medical News about Parkinson Disease

Your Unread Messages

See All

Tracy Hampton, PhD

FDA Update

Anti-CD20 Antibody Granted Accelerated Approval for CLL

Roberta Buell, MBA
Congress Proposes SGR Fix

Dorothy J. Schirf, MD

Technology Advances

Radiosurgery Trial Sparks Optimism for Early Lung Cancer

Sara Hartley

Cancer Science

Hedgehog Pathway Inhibitor Shrinks Medulloblastoma

See All Messages (38 new messages)

Hello, Suzanne Dixon
Manage E-mail | Logout

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Doctors and the DEA Free full text

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Performance on an Alzheimer-selective odor identification test in patients with Parkinsons disease and its relationship with cerebral dopamine transporter activity
Parkinsonism & Related Disorders, 10/29/09

Chou KL et al. – Hyposmia in PD and AD overlap and supposed Alzheimer–selective smell screening tests may not be specific for AD. However, the supposed AD–selective hyposmia scores in PD did not correlate with cerebral DAT binding and may reflect a non–dopaminergic olfactory mechanism.

<< Previous
Clinical Evaluation of the Mini-Mental State Exam with Culturally...

Next >>
Effects of dynamic sitting interventions on tissue oxygenation in...